Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Cell Lung Carcinoma, Extensive Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT05071703
What this trial is testing

Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT04660097
What this trial is testing

Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

Who this might be right for
SCLC, Extensive Stage
Henan Cancer Hospital 34
Testing effectiveness (Phase 2)Study completedNCT00294190
What this trial is testing

Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerCarcinoma, Small Cell
SCRI Development Innovations, LLC 38
Testing effectiveness (Phase 2)Study completedNCT04462276
What this trial is testing

Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease

Who this might be right for
Small Cell Lung Cancer Extensive StageThoracic Radiotherapy
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 68
Not applicableAvailableNCT07535359
What this trial is testing

Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer

Who this might be right for
SCLCExtensive-stage Small Cell Lung Cancer
Daiichi Sankyo
Testing effectiveness (Phase 2)Study completedNCT03913455
What this trial is testing

Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerExtensive-stage Small Cell Lung Cancer
Shadia Jalal, MD 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05765825
What this trial is testing

Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Sichuan University 61
Testing effectiveness (Phase 2)Study completedNCT00003943
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.

Who this might be right for
Carcinoma of Unknown PrimaryLung Cancer
Fox Chase Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT01025284
What this trial is testing

Participants With Small-Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Eli Lilly and Company 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT05384015
What this trial is testing

Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Fundación GECP 46
Testing effectiveness (Phase 2)Looking for participantsNCT05882058
What this trial is testing

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Who this might be right for
Small Cell Lung CarcinomaNeuroendocrine NeoplasmsExtra-pulmonary Neuroendocrine Carcinoma
Boehringer Ingelheim 204
Testing effectiveness (Phase 2)Study completedNCT01262560
What this trial is testing

Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

Who this might be right for
DysphagiaLung CancerPain+1 more
Radiation Therapy Oncology Group 163
Large-scale testing (Phase 3)UnknownNCT00003696
What this trial is testing

Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Commissie Voor Klinisch Toegepast Onderzoek 250
Testing effectiveness (Phase 2)UnknownNCT04901754
What this trial is testing

Camrelizumab Plus Apatinib as Maintenance Therapy in Extensive-stage Small-cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Henan Cancer Hospital 38
Testing effectiveness (Phase 2)UnknownNCT00014547
What this trial is testing

BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Lung Cancer
Theradex
Not applicableEnded earlyNCT00896467
What this trial is testing

Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy

Who this might be right for
Anal CancerAnxiety DisorderBreast Cancer+9 more
Centre Oscar Lambret 200
Large-scale testing (Phase 3)Active Not RecruitingNCT06211036
What this trial is testing

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

Who this might be right for
Extensive-Stage Small-Cell Lung CancerSmall-Cell Lung Cancer
Amgen 563
Large-scale testing (Phase 3)Study completedNCT00003299
What this trial is testing

Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 587
Early research (Phase 1)UnknownNCT03971214
What this trial is testing

PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung CancerRadiotherapyImmunotherapy
Chinese Academy of Medical Sciences 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04472949
What this trial is testing

Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).

Who this might be right for
Small Cell Lung CancerLung Cancer
Swiss Cancer Institute 46
Next Page